Related Experiment Video
Updated: Oct 2, 2025

12:59
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
34.8K
A Pathogenic Th17/CD38+ Macrophage Feedback Loop Drives Inflammatory Arthritis through TNF-α
David E Muench1, Zhe Sun2, Anchal Sharma3
1Immunology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, San Diego, CA.
Journal of Immunology (Baltimore, Md. : 1950)
|February 24, 2022
Summary
Researchers discovered a feedback loop in inflammatory arthritis where macrophages and Th17 cells promote each other
Area of Science:
- Immunology
- Rheumatology
- Cell Biology
Background:
- Rheumatoid arthritis (RA) pathogenesis involves complex immune cell interactions.
- Single-cell studies have identified RA-associated cell subsets but not their functional interplay.
- Understanding cell-cell communication is crucial for elucidating inflammatory arthritis mechanisms.
Purpose of the Study:
- To temporally profile murine arthritic synovial cells using single-cell analysis.
- To identify and characterize interactions between immune cells in inflammatory arthritis.
- To elucidate the role of macrophage-Th17 cell axis in driving arthritis.
Main Methods:
- Single-cell RNA sequencing of murine arthritic synovial isolates.
- In vitro co-culture experiments to assess macrophage-Th17 cell interactions.
- In vivo studies involving macrophage depletion and TNF-α blockade.
Main Results:
- Murine macrophage subtypes expanded in arthritis, promoting Th17 cell function.
- Macrophages maintain Th17 cell functionality and expansion in vitro.
- A reciprocal feedback loop exists where Th17-derived TNF-α induces CD38+ macrophages, enhancing Th17 function.
- CD38+ macrophages are expanded in arthritis; their depletion or TNF-α blockade alleviates disease.
Conclusions:
- A novel TNF-α-mediated feedback loop between macrophages and Th17 cells drives inflammatory arthritis.
- Targeting this macrophage-Th17 cell axis, particularly CD38+ macrophages, holds therapeutic potential for RA.
- This study provides new insights into the cellular mechanisms underlying inflammatory arthritis pathogenesis.
Related Concept Videos
T Cell Types and Functions
1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
Inflammatory Response
10.3K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
10.3K
The JAK-STAT Signaling Pathway
9.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
249
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
249
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
Inflammation
55.9K
Overview
55.9K

